Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD

NCT03781752 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

ADHD
Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Methylphenidate

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]